跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LOTYRO 100 ERLOTINIB FILM COATED TABLETS 100MG - HSA Drug Approval Details
Approvals
/
HSA
/
LOTYRO 100 ERLOTINIB FILM COATED TABLETS 100MG
Approved
THERAPEUTIC
LOTYRO 100 ERLOTINIB FILM COATED TABLETS 100MG
MSN Laboratories Private Limited
🇸🇬 Health Sciences Authority
Approval Date
Sep 11, 2024
Approval ID
90b53145d984274f
Company
MSN Laboratories Private Limited
Type
Therapeutic
Approval Details
Approval Id
90b53145d984274f
Drug Name
LOTYRO 100 ERLOTINIB FILM COATED TABLETS 100MG
Product Name
LOTYRO 100 ERLOTINIB FILM COATED TABLETS 100MG
Approval Number
SIN17081P
Approval Date
2024-09-11
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
L01EB02
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Erlotinib hydrochloride eqv Erlotinib
100.00mg
Erlotinib hydrochloride eqv Erlotinib
100.00mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 11, 2024
Approval ID
90b53145d984274f
Type
Therapeutic
Back to HSA Approvals
